MedPath
FDA Approval

Glatopa

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Sandoz Inc
DUNS: 005387188
Effective Date
December 6, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Glatiramer(40 mg in 1 mL)

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Glatopa

Product Details

NDC Product Code
0781-3250
Application Number
ANDA206921
Marketing Category
ANDA (C73584)
Route of Administration
SUBCUTANEOUS
Effective Date
October 31, 2018
Code: 5M691HL4BOClass: ACTIBQuantity: 40 mg in 1 mL
MANNITOLInactive
Code: 3OWL53L36AClass: IACT

Glatopa

Product Details

NDC Product Code
0781-3234
Application Number
ANDA090218
Marketing Category
ANDA (C73584)
Route of Administration
SUBCUTANEOUS
Effective Date
October 31, 2018
Code: 5M691HL4BOClass: ACTIBQuantity: 20 mg in 1 mL
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
© Copyright 2025. All Rights Reserved by MedPath